Women with rheumatoid arthritis (RA) appear to have better functional status prior to menopause, with a recent study reporting that menopause is associated with a worsening progression of functional decline in RA.
Women who breastfed their infants for a longer duration appeared to have a lower risk of diabetes compared with women who did not breastfeed, according to an observational study spanning three decades.
Women who undergo a hysterectomy with bilateral ovarian conservation appear to have an elevated risk of cardiovascular (CV) and metabolic disease, particularly those who undergo the procedure at age 35 or younger, a recent study found.
There appears to be an inverse relationship between Apgar scores at 5 and 10 minutes and the risk of cerebral palsy and epilepsy, with lower scores corresponding to significantly elevated risks, a recent study has found.
Severe postnatal depression (PND), especially if persisting up to 11 years after birth, raises the risk of adverse child outcomes such as child behavioural and developmental disturbances, according to a recent study.
An early response to neoadjuvant chemotherapy (NACT) in cervical cancer patients is significantly associated with higher disease-free survival (DFS) and improved survival rates, a recent study has shown.
A double intravenous vasopressor automated system appears to be more effective than manual vasopressor bolus administration at controlling maternal blood pressure following spinal anaesthesia during caesarean delivery, a new Singapore study has shown.
Cannabis use during pregnancy increases the risk of maternal anaemia, and causes several adverse outcomes in infants like low birth weight (LBW), and increased neonatal intensive care unit (NICU) admissions, show findings of a systematic review and meta-analysis.
Estrogen receptor α (ESR1) mutations Y537S and D538G are associated with reduced overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer, according to findings of a secondary analysis of the BOLERO-2* clinical trial.